Status:
COMPLETED
Papuan Indigenous Model of Male Circumcision
Lead Sponsor:
University of Illinois at Chicago
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Atma Jaya Catholic University of Indonesia
Conditions:
HIV Infections
Eligibility:
All Genders
15-70 years
Phase:
NA
Brief Summary
The purpose of the study is: AIM 1: To engage Papuan community members to explore acceptability, barriers and facilitators for introducing a school-based age and culturally appropriate, comprehensive ...
Eligibility Criteria
Inclusion
- Resident of either Nabiri or Jayapura Districts of Papua, Indonesia. Able to provide informed consent if over 17 and parental consent and personal assent if less than 18.
- Focus group and interview participants had to be either a parent, boy or girl between 12-18, teacher or administrator, or community leader.
- To be eligible for circumcision, a boy had to be uncircumcised, age 15 years or above, and not show signs or symptoms of an STI or any penile abnormality (e.g., hypospadias, phimosis) that made him clinically ineligible for circumcision.
Exclusion
- Unable to provide informed consent or assent. Any medical condition indicating should not undergo circumcision.
Key Trial Info
Start Date :
September 7 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2023
Estimated Enrollment :
239 Patients enrolled
Trial Details
Trial ID
NCT06212531
Start Date
September 7 2020
End Date
August 31 2023
Last Update
January 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinois Chicago, School of Public Health
Chicago, Illinois, United States, 60612